Health
Messenger RNA vaccines lower risk for asymptomatic infection, study finds – Healio
Participants who received two doses of a messenger RNA COVID-19 vaccine were 80% less likely to test positive for asymptomatic SARS-CoV-2, according to real-world…
Participants who received two doses of a messenger RNA COVID-19 vaccine were 80% less likely to test positive for asymptomatic SARS-CoV-2, according to real-world study results published in Clinical Infectious Diseases.
Even after one dose, the risk for asymptomatic infection was reduced by 79%, researchers reported. The two messenger RNA vaccines authorized for use in the United States are made by Pfizer-BioNTech and Moderna.
“As people are undergoing their routine care and they’re caring for…
-
General19 hours agoWallabies vs Italy rugby union Test live updates — blog, scores and stats from Udine
-
General17 hours agoHow the dismissal of Gough Whitlam’s Labor government in 1975 was sealed by the Senate
-
Noosa News10 hours agoPhotographer Nadia Shevtsova remembered by family in touching tribute after deadly crash at Gold Coast
-
General22 hours agoIsrael identifies latest hostage body as Lior Rudaeff, as families await five more